Read three articles that review immunotherapy treatment options in mesothelioma, small cell lung cancer, and non-small cell lung cancer.
This activity is intended for hematology/oncology specialists, pulmonologists, and pathologists.
The goal of this activity is to increase awareness of immunotherapy as a treatment option for extensive disease in thoracic cancers.
Approximate Time to Complete: 1 hour
Course Available Beginning: Nov. 30, 2016
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Identify barriers to optimizing outcomes with immunotherapy
- Evaluate emerging efficacy data on the use of cancer immunotherapies in the management of thoracic cancer